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Predictors of Problematic Non-Medical Prescription Pain and Stimulant Use
Tess K. Drazdowski, M.S. & Wendy L. Kliewer, Ph.D.
Department of Psychology and Clark-Hill Institute for Positive Youth Development, Virginia Commonwealth University
Recent results from a nationally representative sample 
indicated that young adults exhibited the greatest illicit drug use 
(SAMHSA, 2013b). The non-medical use of prescription drugs 
(NMUPD) is the second most commonly reported form of illicit 
substance use by young adults, preceded only by marijuana 
(SAMHSA, 2013b). This is a growing public health concern with 
an estimated 2.4 million Americans engaging in NUMPD for the 
first time within the past year in 2010, an average of 6,600 
initiates per day (SAMHSA, 2013b). Prescription opioid abuse 
alone was estimated to cost the U.S. $55.7 billion in 2007 
(Birnbaum et al., 2011). NMUPD has been linked with abuse and 
dependence, and a variety of other negative outcomes, including 
mental illness (e.g., Bavarian et al., 2013), poor school 
performance (Arria et al., 2011), emergency room visits 
(SAMHSA, 2013a, 2013b), more frequent sexual risk behaviors 
(Benotsch et al., 2011), and death (CDC, 2012; Paulozzi et al., 
2012). Additionally, young adults who engage in NMUPD are 
significantly more likely than their peers to use other illicit drugs 
and to combine prescription drugs with alcohol and other 
substances. These practices increase the risk of potentially 
dangerous drug interactions, and their negative outcomes 
(Garnier et al., 2009; McCabe et al., 2006; SAMHSA, 2006). 
Therefore, prevention is key to reducing this great public health 
concern and its grave costs to society. One way to prevent 
substance use and abuse is to investigate why specific groups of 
people use and to target interventions specifically to modifiable 
predictors. The current study focuses on such potential predictors.
 To determine the predictors of problematic non-medical use of 
prescription stimulants and opioids in an undergraduate sample of 
young adults.
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Participants
 193 undergraduate students attending a large public university
 70.4% female; 55% White
 Endorsed NMUPD of either pain or stimulant medications in the 
past year
Design
 First, regressions were conducted to test whether sleep 
problems, emotion regulation difficulties, depressive symptoms, 
and post-traumatic stress disorder (PTSD) symptoms predicted 
problematic non-medical use of either prescription stimulants or 
opioids. 
 Then, the significant predictors from the previous regression 
models were entered into two separate multiple regression 
models, one for problematic stimulant misuse and another for 
problematic opioid misuse to determine which predictor was the 
most influential. 
METHODS
Measures
Participants completed an online questionnaires and received research 
credit for an Introduction to Psychology class as compensation. For the 
current study these included: 
 Reduce Annoyed Guilty Start test (RAGS; Sobell et al., 1999): The 32-item 
RAGS self-report scale was modified to examine four aspects of problem 
NMUPD usage: need to stop or reduce behavior, annoyance from  others 
criticizing the behavior, guilt about the behavior, and needing the behavior 
to start the day. This version asked these questions in terms of prescription 
opioids and stimulants. Higher scores indicated greater problem usage.
 Pittsburgh Sleep Quality Index (PSQI; Buysse et al., 1989): The 19-item 
self-report scale measures seven components of sleep over the past 
month: sleep quality, sleep latency, duration of sleep, sleep efficiency, 
disturbances of sleep, use of sleep medication, and daytime dysfunction. 
Higher global PSQI scores indicated worse sleep problems or worsened 
quality of sleep.
 Difficulties in Emotion Regulation Scale (DERS; Gratz & Roemer, 2004): 
The 36-item self-report scale assessed emotion regulation in four domains: 
awareness and understanding of one’s emotions, acceptance of emotions, 
ability to engage in goal directed behavior and abstain from impulsive 
behavior when faced with negative emotions, and whether one’s access to 
emotion regulation strategies seemed effective. Higher scores indicated 
greater difficulties in emotion regulation.
 Center for Epidemiological Studies Depression Scale (CES-D; Radloff, 
1991): The 20-item self-report scale has participants rate the frequency of 
which each of the statements was true for them in the past week. Higher 
scores indicated greater frequency and severity of depressive symptoms.
 The Impact of Event  Scale (IES; Horowitz et al., 1979): The 15-item self-
report measure assesses participants after experiencing a traumatic event. 
The scale asks participants to rate to what extent each of the items are true 
for them in the previous seven days. Higher scores indicate greater 
problems and more PTSD symptoms.
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 These results suggest that all of these predictors are important to consider 
when investigating NMUPD in young adults. 
Limitations
 All data collected was through self-report measures which are subject to 
participants responding in a socially desirable context.
 The characteristics of this population (undergraduate students at one 
university) need to be considered with regards to the generalizability of these 
results. 
 Since results from treatment research investigating abuse of other 
substances have found that integrated approaches that combine mental 
health and substance use are more effective than interventions that address 
substance use and mental health problems separately (e.g., Drake et al., 
2008), future prevention and intervention efforts should consider all of the 
variables investigated. 
 If resources are limited targeting PTSD symptoms may be the most 
effective. Contact: Tess K. Drazdowski
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 Using regression models run separately for users of pain and stimulant 
medications, emotion regulation difficulties and PTSD symptoms were found to 
predict non-medical problematic use of both pain and stimulant medication. 
 Sleep problems and depressive symptoms were found to only predict problematic 
use of stimulants. 
 When all the significant predictors were entered into a multiple regression for 
each prescription category, no one predictor was significant above and beyond other 
predictors (see Table 1). 
 However, PTSD symptoms explained the most variance in both models.
Prescription Drug 
Category
Predictor B SE B Β p
Pain DERS 0.01 0.01 .19 .19
IES 0.02 0.01 .21 .09
R2 .09
Stimulant DERS .00 .01 .05 .79
IES .01 .01 .19 .22
PSQI .05 .06 .14 .37
CES-D .02 .02 .14 .50
R2 .17
Table 1
Multiple Regression Analysis Examining Associations Among Significant 
Correlates and Problematic Non-medical Use of Pain and Stimulant Medications 
(N = 193)
Note.  DERS = Difficulties in Emotion Regulation Scale, IES = Impact of Events Scale, 
PSQI = Pittsburgh Sleep Quality Index, CES-D = Center for Epidemiological Studies –
Depression Scale.
